Genesis Therapeutics, Inc.
Biotechnology company · Burlingame, California, United States
Genesis Therapeutics, Inc. is a biotechnology company headquartered in Burlingame, California, United States. Its earliest recorded incorporation is in 2019. It has reported private securities offerings to the US SEC, most recently $224 million sold in a notice filed in 2023.
Genesis Therapeutics at a glance
What does Genesis Therapeutics do?
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $224 million sold (2023).
Frequently asked questions about Genesis Therapeutics
Where is Genesis Therapeutics headquartered?
Genesis Therapeutics, Inc. is headquartered in Burlingame, California, United States.
What does Genesis Therapeutics do?
Genesis Therapeutics, Inc. is a biotechnology company.
When was Genesis Therapeutics founded?
The earliest incorporation on record for Genesis Therapeutics, Inc. is in 2019, according to public company registers.
Similar companies
- Inflammatix, Inc.Burlingame, California, United States
- Hinge Bio, Inc.Burlingame, California, United States
- Magnus Medical, Inc.Burlingame, California, United States
- Optofluidics, Inc.Burlingame, California, United States
- Afasci, Inc.Burlingame, California, United States
- Nextrast, IncBurlingame, California, United States
- Attralus, Inc.Burlingame, California, United States
- Biodesy LLCBurlingame, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences